Filing Flows › MSCI (MSCI) › R&D spending
MSCI (MSCI) R&D spending by quarter
MSCI's R&D spending was $47.6M in Q3 2026 (third quarter 2026), +3% from Q2 2026. Over the last 7 quarters it ranged from $41.1M (Q4 2025) to $49.6M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $47.6M | +3% | +6% |
| Q2 2026 | $46.0M | -7% | +4% |
| Q1 2026 | $49.6M | +21% | +4% |
| Q4 2025 | $41.1M | -8% | — |
| Q3 2025 | $44.8M | +2% | — |
| Q2 2025 | $44.1M | -7% | — |
| Q1 2025 | $47.6M | — | — |
Q3 2026 at a glance
MSCI, Q3 2026: revenue $892M (+12% year over year), operating margin 56.3%, net earnings $351M, operating cash flow $436M. The chart follows the revenue to costs, profit and cash.
Questions
What is MSCI's R&D spending?
MSCI's R&D spending was $47.6M in Q3 2026 (third quarter 2026), +3% from Q2 2026.
How has MSCI's R&D spending changed?
Over the last 7 quarters it ranged from $41.1M (Q4 2025) to $49.6M (Q1 2026).